Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
are seeking a fast-paced academic research environment. Our lab in the Department of Immuno-Oncology focuses on engineering tumor-colonizing bacteria to target components of the tumor microenvironment
-
to groundbreaking projects, employing high-throughput CRISPR genetic screening to unveil novel targets and utilizing single-cell technology for in-depth genome analysis in hematological malignancies. You will also
-
to groundbreaking projects, employing high-throughput CRISPR genetic screening to unveil novel targets and utilizing single-cell technology for in-depth genome analysis in hematological malignancies. You will also
-
immune checkpoints and ligands on various hematopoietic malignant and solider tumor cells with high-throughput screening and protein engineering approaches developed in the lab, and develop novel cancer
-
and identification of HLA-restricted epitopes derived from them As a successful candidate, you will: · Work with both genetically engineered mouse models, patient-derived AML xenograft models
-
Advanced written and verbal communication skills Proficient with technology, spreadsheet management skills, with the ability to analyze trends. Excellent organizational skills, ability to manage multiple
-
, shaping the future of medicine through cutting-edge research. The Department of Integrative Translational Sciences at City of Hope comprises a diverse team of biologists, data scientists, engineers
-
Mathematics, Statistics, Physics, Computer Science, Engineering or related discipline Experience with genome sequencing data (ex. DNA, RNA, ATAC seq) Experience with stochastic dynamical systems and probability
-
and identification of HLA-restricted epitopes derived from them As a successful candidate, you will: · Work with both genetically engineered mouse models, patient-derived AML xenograft models
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and